Do All Patients with Breast Cancer Require Systemic Adjuvant Therapy?

被引：1
作者：
Griggs, Jennifer J. [1 ]
Hayes, Daniel F. [1 ]
机构：
[1] Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2011年 / 103卷 / 18期
关键词：
AMERICAN SOCIETY; TAMOXIFEN; RECURRENCE; RISK; PREVENTION; MORTALITY; UPDATE; WOMEN; ASSAY;
D O I：
10.1093/jnci/djr331
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1350 / 1351
页数：2
相关论文
共 19 条
  • [1] Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
  • [2] ARNESSON LG, 1994, EUR J SURG, V160, P271
  • [3] Effect of screening and adjuvant therapy on mortality from breast cancer
    Berry, DA
    Cronin, KA
    Plevritis, SK
    Fryback, DG
    Clarke, L
    Zelen, M
    Mandelblatt, JS
    Yakovlev, AY
    Habbema, JDF
    Feuer, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) : 1784 - 1792
  • [4] Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI [10.1200/JCO.2009.26.3756, 10.1200/JOP.000082]
  • [5] Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark
    Christiansen, Peer
    Bjerre, Karsten
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Rasmussen, Birgitte B.
    Laenkholm, Anne-Vibeke
    Kroman, Niels
    Ewertz, Marianne
    Offersen, Birgitte
    Toftdahl, Dorte B.
    Moller, Susanne
    Mouridsen, Henning T.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (18): : 1363 - 1372
  • [6] HER2 and hormone receptor-positive breast cancer-blocking the right target
    Cortes, Javier
    Saura, Cristina
    Bellet, Meritxell
    Munoz-Couselo, Eva
    Ramirez-Merino, Natalia
    Calvo, Virginia
    Perez, Jose
    Vidal, Maria
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (05) : 307 - 311
  • [7] Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
    Dowsett, Mitch
    Cuzick, Jack
    Wale, Christopher
    Forbes, John
    Mallon, Elizabeth A.
    Salter, Janine
    Quinn, Emma
    Dunbier, Anita
    Baum, Michael
    Buzdar, Aman
    Howell, Anthony
    Bugarini, Roberto
    Baehner, Frederick L.
    Shak, Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1829 - 1834
  • [8] Early Breast Cancer Trialists' Collaborative Group, 2001, Cochrane Database Syst Rev
  • [9] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
    Fisher, B
    Costantino, JP
    Wickerham, DL
    Redmond, CK
    Kavanah, M
    Cronin, WM
    Vogel, V
    Robidoux, A
    Dimitrov, N
    Atkins, J
    Daly, M
    Wieand, S
    Tan-Chiu, E
    Ford, L
    Wolmark, N
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) : 1371 - 1388
  • [10] Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less
    Fisher, B
    Bryant, J
    Dignam, JJ
    Wickerham, DL
    Mamounas, EP
    Fisher, ER
    Margolese, RG
    Nesbitt, L
    Paik, S
    Pisansky, TM
    Wolmark, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4141 - 4149
12